● Recruiting

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

Condition: Schizophrenia · Schizoaffective Disorder · Bipolar Disorder · Sponsor: Neurocrine Biosciences

PhasePhase 4

Planned participants50

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This study will evaluate the efficacy of valbenazine on clinician- and patient-reported outcomes in participants with TD while receiving or after stopping a VMAT2 inhibitor.

This description comes directly from the study's public registry record.

Talk to the study team

Neurocrine Medical Information Call Center · 1-877-641-3461 · medinfo@neurocrine.com

Always discuss trial participation with your own doctor first.

Locations (22)

Neurocrine Clinical Site	Bryant, Arkansas, United States	Recruiting
Neurocrine Clinical Site	Chino, California, United States	Recruiting
Neurocrine Clinical Site	Fountain Valley, California, United States	Recruiting
Neurocrine Clinical Site	Fresno, California, United States	Recruiting
Neurocrine Clinical Site	Long Beach, California, United States	Recruiting
Neurocrine Clinical Site	Orange, California, United States	Recruiting
Neurocrine Clinical Site	Redlands, California, United States	Recruiting
Neurocrine Clinical Site	San Diego, California, United States	Recruiting
Neurocrine Clinical Site	Bonita Springs, Florida, United States	Recruiting
Neurocrine Clinical Site	Hialeah, Florida, United States	Recruiting
Neurocrine Clinical Site	Miami, Florida, United States	Recruiting
Neurocrine Clinical Site	Miami, Florida, United States	Recruiting

+ 10 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07105111